| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/18/2004 | EP1446404A1 Rosiglitazone edisylates and their use as antidiabetics |
| 08/18/2004 | EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |
| 08/18/2004 | EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof |
| 08/18/2004 | EP1446161A2 Medicinal combination of biguanine (metformin) and arginine |
| 08/18/2004 | EP1446132A2 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446022A1 Oilseed processing |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1252170B1 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1189924B1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 08/18/2004 | EP1179343B1 Remedies for diabetes comprising 2-(n-cyanoimino)thiazolidine-4-one derivatives |
| 08/18/2004 | EP1117676B1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 08/18/2004 | EP1037636A4 Inhibition of membrane-associated viral replication |
| 08/18/2004 | EP1012188B1 Composition for treating diabetes mellitus and obesity |
| 08/18/2004 | EP0909171B1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 08/18/2004 | EP0871474A4 Generation of human insulin |
| 08/18/2004 | EP0862622B1 Method of screening for RAC protein kinase interacting compounds |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522253A Novel heterocyclic derivatives and medicinal use thereof |
| 08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
| 08/18/2004 | CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1521189A Analogs of parathyroid hormone |
| 08/18/2004 | CN1521176A Method for producing highly pure acarbose |
| 08/18/2004 | CN1521175A Bitter leaf naphthalene extract and its use |
| 08/18/2004 | CN1521157A Protein tyrosine phosphatase 1B inhibitor para-benzoquinone compound and process for preparing the same |
| 08/18/2004 | CN1520858A Diabetes treating thirsty-dispelling drop pills |
| 08/18/2004 | CN1520857A Diabetes treating bitter gourd traditional Chinese medicine |
| 08/18/2004 | CN1520853A Sonchifolia Hance solid medical preparation and its manufacture process |
| 08/18/2004 | CN1520852A Sonchifolia Hance oral liquid and its manufacture process |
| 08/18/2004 | CN1520838A Bitter gourd extract plant insulin ; novel use of bitter gourd saponin |
| 08/18/2004 | CN1162446C Insulinotropic hormone secretion peptide derivative |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine |
| 08/18/2004 | CN1162349C Mineralized drinking water and its prepn |
| 08/18/2004 | CN1162348C Slow-releasing phosphate glass nutritive agent and its preparing process |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/18/2004 | CN1162174C Medicine for treating diabetes |
| 08/18/2004 | CN1162164C Diabetes treating medicine and its preparation |
| 08/18/2004 | CN1162153C Benzothiophenes series, formulations containing same, and methods |
| 08/18/2004 | CN1162152C Remedies for diabetes |
| 08/18/2004 | CN1162096C Potassium calcium citrate compositions and methods for production |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777560 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777442 Diphenyl derivatives |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777435 Retinoid-related receptor function regulating agent |
| 08/17/2004 | US6777414 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 08/17/2004 | US6777410 Isoindole derivatives |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777407 7bh-cyclopenta(b)(1,4)diazepino(6, 7, 1-hi)indole or a salt, useful for treatment of schizophrenia, obsessive compulsive disorder, depression, anxiety, panic disorder, obesity or epilepsy |
| 08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
| 08/17/2004 | US6777404 Use of corticotropin releasing factor antagonists and related compositions |
| 08/17/2004 | US6777397 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2122908C Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/14/2004 | CA2457465A1 Method for reducing the glycemic index of food |
| 08/12/2004 | WO2004067550A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 08/12/2004 | WO2004067542A1 Oligosaccharide derivative |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067525A1 Vitamin d3 lactone derivative |
| 08/12/2004 | WO2004067516A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/12/2004 | WO2004067509A1 Compound inhibiting dipeptidyl peptidase iv |
| 08/12/2004 | WO2004067506A2 Substituted heterocyclic compounds |
| 08/12/2004 | WO2004067504A1 2-substituted vitamin d derivative |
| 08/12/2004 | WO2004067496A1 Crystalline form of nateglinide |
| 08/12/2004 | WO2004067489A2 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 08/12/2004 | WO2004067011A1 Amelioration of decreased weight and growth by n-acylated glucosamines |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004067001A1 Process for producing coated preparation |
| 08/12/2004 | WO2004066988A1 Fatigue reducing agent |
| 08/12/2004 | WO2004052286A3 Tyrosine kinase inhibitors |
| 08/12/2004 | WO2004031374A3 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/12/2004 | WO2003051182A3 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003026573A3 Screening and selection methods for statin drug combinations |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040157934 Central nervous system disorders; psychological disorders ; administering dosage og dopamine, serotonin and sibutramine |